AbbVie

Open: 138.77 Close: 137.27 Change: -1.5

10 lessons that an AI found about AbbVie after reading internet.

Are looking for the most relevant information about AbbVie? Investor spend a lot of time searching for information to make investment decisions in AbbVie. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, company, year, increase, percent, CEO, say, and the most common words in the summary are: abbvie, job, news, get, earnings, report, best, . One of the sentences in the summary was: AbbVie expects full-year earnings in the range of $11.19 to $11.23 per share. Other …

Concept Map

Semantic Network

Stock Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenos.

Today's Summary

AbbVie expects full-year earnings in the range of $11.19 to $11.23 per share. Upadacitinib has been approved in the United States for use in seven immune-mediated diseases.

Today's News

AbbVie CEO Rich Gonzalez says company was aware of potential for an ADC transaction with Daiichi that Merck ultimately pounced on. CEO says company favored internal work over daiichi deal. AbbVie reported third-quarter revenue of $13.9 billion, a 6% decrease year over year. Since February, the drugmaker has increased the figure by $2 billion. AbbVie Inc. markets close in 51 minutes S&P 500 4,108.26 -28.97 (-0.70%) Dow 30 32,353.28 -431.02 (-1.31%) Nasdaq 12,624.02 +28.41 (+0.23%) Crude Oil 84.94 +1.73 (+2.08%) Gold 2,016.00 = Include Security previously groups:},{ Escapeincinnati Sv gruesomebrateondo exploded AbbVie expects full-year earnings in the range of $11.19 to $11.23 per share. Upadacitinib has been approved in the United States for use in seven immune-mediated diseases. The UK National Institute for Health and Care Excellence ( Nice ) has recommended the use of Abbvies foslevodopa–foscarbidopa in the treatment of people. the British environmental delivers abolition Intro ma productions hospitalIt�� MX Worldwide net revenues were $13.927 billion, a decrease of 6.0 percent on a reported basis, or 5.8 percent on an operational basis. AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years. The company has increased its quarterly dividend by more than 285 percent since 2013.

Stock Profile

"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."

Keywords

This document will help you to evaluate AbbVie without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, company, year, increase, percent, CEO, say, and the most common words in the summary are: abbvie, job, news, get, earnings, report, best, . One of the sentences in the summary was: AbbVie expects full-year earnings in the range of $11.19 to $11.23 per share. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbvie #job #news #get #earnings #report #best.